CN103169940A - Drug for treating facioplegia - Google Patents

Drug for treating facioplegia Download PDF

Info

Publication number
CN103169940A
CN103169940A CN2013101312294A CN201310131229A CN103169940A CN 103169940 A CN103169940 A CN 103169940A CN 2013101312294 A CN2013101312294 A CN 2013101312294A CN 201310131229 A CN201310131229 A CN 201310131229A CN 103169940 A CN103169940 A CN 103169940A
Authority
CN
China
Prior art keywords
parts
drug
radix
facioplegia
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013101312294A
Other languages
Chinese (zh)
Other versions
CN103169940B (en
Inventor
薛洪喜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haimen Mingyang Industrial Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310131229.4A priority Critical patent/CN103169940B/en
Publication of CN103169940A publication Critical patent/CN103169940A/en
Application granted granted Critical
Publication of CN103169940B publication Critical patent/CN103169940B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a drug for treating facioplegia. The common symptoms of the facioplegia are local cold invasion, sudden onset, slobbering, oblique, hypogeusia, hyperacousia, the situations that the eyelid cannot be closed or completely closed; the lower eyelid is valgus, and weeps; and nasolabial groove becomes flat and hollow; quarrel prolapse, slant uninjured side, saliva outflow, and the situation that the actions such as cheek-bulging, tapir mouth, blowing whistle and the like cannot be finished. The sick side muscle generates involuntary twitch at times. The inventor finally finds out the traditional Chinese medicine oral drug with a better curative effect for treating facioplegia by a long-range research and clinical verification. The dosage of the drug component disclosed by the invention is fumbled by the inventor; the optimum proportions are 4 parts of scorpio, 9 parts of stiff silkworm, 9 parts of rhizoma typhonii, 10 parts of radix stephaniae tetrandrae, 10 parts of almond, 10 parts of cassia twig, 15 parts of radices sileris, 10 parts of ligusticum wallichii, 10 parts of radix paeoniae alba, 10 parts of codonopsis pilosula, 6 parts of ginger, 6 parts of liquorice and 3 parts of asarum. By adopting these drug compositions, each drug generates the synergistic effect, and the drug has the effects of warming and promoting channels, eliminating cold to stop pain, and activating meridians to stop pain, so as to effectively treat the facioplegia.

Description

A kind of medicine of facial paralysis
Technical field
The present invention relates to a kind of Chinese herbal medicine, especially a kind of Chinese herbal medicine of facial paralysis.
Background technology
The facial paralysis common sympton is for there being the part invasion and attack history of having a cold, and suddenly, slobbering is oblique, hypogeusia, hyperakusis in morbidity, eyelid can not closure or dysraphism, palpebra inferior turns up, and sheds tears, smooth the shoaling of sick side nasolabial groove, ptosis of labial angle, askew to strong side, the outflow of mouthful saliva, the action such as can not complete the bulging cheek, pout one's lips, blow a whistle.There is the seasonal disease side face muscle that involuntary twitch occurs.
Summary of the invention
The inventor is through studying for a long period of time, and, by the checking repeatedly of clinical trial, finally found the extract oral medicine that is used for the treatment of facial paralysis that better curative effect is arranged, and this medicine has promoting the flow of QI-blood by warming the meridian, damp eliminating cold expelling, removing obstruction in the collateral to relieve pain curative effect.
Technical assignment of the present invention is to provide a kind of Chinese medicine composition of more efficiently facial paralysis.Medicament selection Scorpio of the present invention, Bombyx Batryticatus, Rhizoma Typhonii, Radix Stephaniae Tetrandrae, Semen Armeniacae Amarum, Ramulus Cinnamomi, Radix Saposhnikoviae, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Radix Codonopsis, Rhizoma Zingiberis Recens, Radix Glycyrrhizae, Herba Asari are combined, make each efficacy of drugs produce synergism these drug regimens, thus effective facial paralysis.Wherein: Scorpio: be the dry body of Buthidae animal Scorpio.The property hot, flat.Poisonous.Return Liver Channel.Relieving spasm by subduing liver-wind, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain.
Bombyx Batryticatus: for the larva of Bombycidae insecticide bombyx mori before not weaving silk, because infecting the muscardine lethal dry body of falling ill.The property salty, hot, flat.Return liver, lung meridian.The endogenous wind stopping relieving convulsion, wind-expelling pain-stopping, dissipating phlegm and resolving masses.
Rhizoma Typhonii: be the processed goods of Ranunculaceae herbaceous plant Aconitum carmichjaelii Debx. daughter root.Property is sweet, hot, heat.Return kidney, liver, the heart, spleen channel.Recuperating depleted YANG and rescuing the patient from collapse, mend fire supporing yang, dispersing cold for relieving pain.
Radix Stephaniae Tetrandrae: be the root of the perennial bejuco Radix stephaniae tetrandrae of Menispermaceae or the perennial voluble herb plant of Aristolochiaceae Radix Aristolochiae Fangchi.The property bitter, acrid, cold.Return bladder, kidney, spleen channel.Wind-damp dispelling, pain relieving, inducing diuresis to remove edema.
Semen Armeniacae Amarum: be the seed of the bitter in the mouth such as rosaceous plant Fructus Pruni or Prunus armeniaca L.var.ansu Maxim..The property bitter, warm.Return lung, large intestine channel.Relieving cough and asthma, loosening bowel to relieve constipation.
Ramulus Cinnamomi: be the twig of Lauraceae magaphanerophytes Cortex Cinnamomi.The property acrid, sweet, warm.Return lung, the heart, kidney,liver,spleen warp.There is relieving the exterior syndrome by diaphoresis, promoting the flow of QI-blood by warming the meridian, the effect of warm aid yang qi.
Radix Saposhnikoviae: be the root of Umbelliferae herbaceos perennial Radix Saposhnikoviae.The property hot, sweet, tepor.Return bladder, liver, spleen channel.Deliver loose wind, removing dampness to relieve pain, relieving convulsion, antidiarrheal.
Rhizoma Chuanxiong: be the rhizome of Umbelliferae herbaceos perennial Rhizoma Chuanxiong.The property suffering, temperature.GUIXIN, Liver Channel.There is blood-activating and qi-promoting, the effect of wind-expelling pain-stopping.
The Radix Paeoniae Alba: be the root of Ranunculaceae herbaceos perennial Radix Paeoniae.Property is sweet, sour, is slightly cold.Return liver, the heart, spleen channel.Enrich blood, suppressing liver-YANG, relieving spasm to stop pain, hidroschesis.
Radix Codonopsis: be the root of campanulaceae herbaceos perennial Radix Codonopsis.The property sweet, flat.Return spleen, lung meridian.The spleen reinforcing lung qi, enrich blood, and invigorating the spleen and benefiting QI, the colporrhagia lower abdomen heavily fallen to the effect that nourishing qi to stop is arranged, and tire had contained.
Rhizoma Zingiberis Recens: be the rhizome of Zingiberaceae herbaceos perennial Rhizoma Zingiberis Recens.The property suffering, temperature.Return lung, spleen, stomach warp.Relieving the exterior syndrome by diaphoresis, warming middle-JIAO to arrest vomiting, warming the lung to relieve cough.
Radix Glycyrrhizae: be the rhizome of pulse family herbaceos perennial Radix Glycyrrhizae.Property is sweet, is slightly cold.GUIXIN, lung, spleen, stomach warp.Reinforcing the heart temper, relieving spasm to stop pain, heat-clearing and toxic substances removing, the mediation property of medicine.
Herba Asari: be the herb of Aristolochiaceae herbaceos perennial Herba Asari, Seoul Herba Asari or magnificent Herba Asari.The property suffering, temperature.Slightly poisonous.Return lung, kidney, heart channel.Expelling wind and cold, sensible, pain relieving, warming the lung to resolve fluid-retention.
The consumption of drug component of the present invention also gropes to draw through the inventor in a large number, and each amounts of components is for to have curative effect preferably in the following weight proportioning: Scorpio 2-5 part, Bombyx Batryticatus 3-10 part, Rhizoma Typhonii 3-15 part, Radix Stephaniae Tetrandrae 5-10 part, Semen Armeniacae Amarum 4-10 part, Ramulus Cinnamomi 10-15 part, Radix Saposhnikoviae 3-15 part, Rhizoma Chuanxiong 3-10 part, Radix Paeoniae Alba 10-20 part, Radix Codonopsis 10-30 part, Rhizoma Zingiberis Recens 3-10 part, Radix Glycyrrhizae 3-10 part, Herba Asari 2-5 part.
Its best proportioning is: 4 parts of Scorpios, 9 parts of Bombyx Batryticatus, 9 parts of Rhizoma Typhoniis, 10 parts of Radixs Stephaniae Tetrandrae, 10 parts, Semen Armeniacae Amarum, 10 parts of Ramulus Cinnamomi, 15 parts of Radix Saposhnikoviaes, 10 parts of Rhizoma Chuanxiongs, 10 parts of the Radix Paeoniae Albas, 10 parts of Radix Codonopsis, 6 parts, Rhizoma Zingiberis Recens, 6 parts, Radix Glycyrrhizae, 3 parts of Herba Asaris.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, as pill, powder, tablet, oral liquid etc.For example these crude drug pulverize mix homogeneously can be made to powder takes after mixing it with water; Can use decocting, obtain after filtration filtrate, make oral liquid; Also can directly take decoction in case of necessity.
Medicine of the present invention has the effect of promoting the flow of QI-blood by warming the meridian, damp eliminating cold expelling, removing obstruction in the collateral to relieve pain, short treating period, evident in efficacy, without any side effects, according to clinical 210 routine patients are observed to statistics, take 84.76%, three of 75.24%, two of one of the medicine of the present invention obvious effective rate course for the treatment of obvious effective rate course for the treatment of obvious effective rate course for the treatment of 92.86%.
The specific embodiment
Take following each medicine:
4 parts of Scorpios, 9 parts of Bombyx Batryticatus, 9 parts of Rhizoma Typhoniis, 10 parts of Radixs Stephaniae Tetrandrae, 10 parts, Semen Armeniacae Amarum, 10 parts of Ramulus Cinnamomi, 15 parts of Radix Saposhnikoviaes, 10 parts of Rhizoma Chuanxiongs, 10 parts of the Radix Paeoniae Albas, 10 parts of Radix Codonopsis, 6 parts, Rhizoma Zingiberis Recens, 6 parts, Radix Glycyrrhizae, 3 parts of Herba Asaris.
Said medicine is put in mortar and ground well successively, cross 100 mesh sieves, then packing two pouches; While taking one day twice once a bag, 15 days is a course for the treatment of.
Below the clinical data that the patient uses medicine of the present invention:
One, physical data
Accept patient's totally 210 examples for medical treatment, all make a definite diagnosis on inspection, its age 27-59 year, average 43 years old.
Two, diagnostic criteria
The part invasion and attack history of having a cold is arranged, and suddenly, slobbering , is oblique, hypogeusia in morbidity, hyperakusis, eyelid can not closure or dysraphism, and palpebra inferior turns up, and sheds tears, smooth the shoaling of sick side nasolabial groove, ptosis of labial angle, askew to strong side, the outflow of mouthful saliva, the action such as can not complete the bulging cheek, pout one's lips, blow a whistle.There is the seasonal disease side face muscle that involuntary twitch occurs.
Three, Therapeutic Method
The patient takes medicine of the present invention, and one day twice, once a bag.
Four, efficacy assessment standard
Produce effects: after finishing the course for the treatment of, clinical symptoms disappears fully.
Take a turn for the better: symptom is alleviated substantially.
Invalid: remission is not obvious.
Five, therapeutic outcome
Treatment time Produce effects (example) Obvious effective rate % Take a turn for the better (example) Improvement rate % Invalid (example) Inefficiency %
One course for the treatment of 158 75.24 42 20.00 10 4.76
Two courses for the treatment of 178 84.76 24 11.44 8 3.80
Three courses for the treatment of 195 92.86 10 4.76 5 2.38
Model case:
One, Mrs Li, 42 years old, the From Shandong Rizhao people, had the part invasion and attack history of having a cold, wake up morning and find that slobbering, is oblique, eyelid can not be closed, shed tears, smooth the shoaling of sick side nasolabial groove, ptosis of labial angle, askew to strong side, the outflow of mouthful saliva, the action such as can not complete the bulging cheek, pout one's lips, blow a whistle.
Take medicine of the present invention after course for the treatment of, patient's slobbering, oblique, and eyelid can not be closed, shed tears etc. alleviates, and continues to take medicine of the present invention after course for the treatment of, and slobbering, oblique, and eyelid can not closed, the disappearance of shedding tears, and continues to consolidate a course for the treatment of curative effect.
Two, Wang man, 37 years old, the Heze City, Shandong Province people, the part invasion and attack history of having a cold is arranged, and slobbering, oblique suddenly, hypogeusia, hyperakusis, hypophasis, smooth the shoaling of sick side nasolabial groove, ptosis of labial angle, askew to strong side, the outflow of mouthful saliva, the action such as can not complete the bulging cheek, pout one's lips, blow a whistle, involuntary twitch occurs in sick side face muscle sometimes.
The present invention taking a course of medication, the patient feels the symptoms were relieved, mouth drooling, oblique, taste loss, hyperacusis, incomplete eyelid closure was significantly reduced, mouth drooling, oblique disappear, continue taking the drug after a course of the present invention can completion of the drum gills, pouting, whistle and other actions, to continue a course of consolidation effect.

Claims (2)

1. the medicine of a facial paralysis, is characterized in that it is made by the crude drug of following weight proportion: Scorpio 2-5 part, Bombyx Batryticatus 3-10 part, Rhizoma Typhonii 3-15 part, Radix Stephaniae Tetrandrae 5-10 part, Semen Armeniacae Amarum 4-10 part, Ramulus Cinnamomi 10-15 part, Radix Saposhnikoviae 3-15 part, Rhizoma Chuanxiong 3-10 part, Radix Paeoniae Alba 10-20 part, Radix Codonopsis 10-30 part, Rhizoma Zingiberis Recens 3-10 part, Radix Glycyrrhizae 3-10 part, Herba Asari 2-5 part.
2. medicine according to claim 1, is characterized in that it is made by the crude drug of following weight proportion: 4 parts of Scorpios, 9 parts of Bombyx Batryticatus, 9 parts of Rhizoma Typhoniis, 10 parts of Radixs Stephaniae Tetrandrae, 10 parts, Semen Armeniacae Amarum, 10 parts of Ramulus Cinnamomi, 15 parts of Radix Saposhnikoviaes, 10 parts of Rhizoma Chuanxiongs, 10 parts of the Radix Paeoniae Albas, 10 parts of Radix Codonopsis, 6 parts, Rhizoma Zingiberis Recens, 6 parts, Radix Glycyrrhizae, 3 parts of Herba Asaris.
CN201310131229.4A 2013-04-16 2013-04-16 Drug for treating facioplegia Expired - Fee Related CN103169940B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310131229.4A CN103169940B (en) 2013-04-16 2013-04-16 Drug for treating facioplegia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310131229.4A CN103169940B (en) 2013-04-16 2013-04-16 Drug for treating facioplegia

Publications (2)

Publication Number Publication Date
CN103169940A true CN103169940A (en) 2013-06-26
CN103169940B CN103169940B (en) 2014-04-09

Family

ID=48630427

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310131229.4A Expired - Fee Related CN103169940B (en) 2013-04-16 2013-04-16 Drug for treating facioplegia

Country Status (1)

Country Link
CN (1) CN103169940B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825846A (en) * 2015-04-16 2015-08-12 湖州品创孵化器有限公司 Traditional Chinese medicinal composition for treating facial neuritis
CN104825856A (en) * 2015-04-16 2015-08-12 湖州品创孵化器有限公司 Traditional Chinese medicinal composition for treating facial paralysis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101066439A (en) * 2007-05-29 2007-11-07 孙书卿 Wind dispelling and obstruction eliminating capsule and its prepn
CN101919920A (en) * 2009-06-12 2010-12-22 景玲 Traditional Chinese medicine preparation for treating wind syndrome and facial paralysis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101066439A (en) * 2007-05-29 2007-11-07 孙书卿 Wind dispelling and obstruction eliminating capsule and its prepn
CN101919920A (en) * 2009-06-12 2010-12-22 景玲 Traditional Chinese medicine preparation for treating wind syndrome and facial paralysis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《中国中医药报》 20120601 高允旺 《小续命汤--治脑出血金方》 004板 , *
余小平: "《小续命汤加减治疗脑梗塞30 例》", 《湖南中医杂志》, 31 December 1996 (1996-12-31), pages 21 - 22 *
高允旺: "《小续命汤——治脑出血金方》", 《中国中医药报》, 1 June 2012 (2012-06-01), pages 004 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825846A (en) * 2015-04-16 2015-08-12 湖州品创孵化器有限公司 Traditional Chinese medicinal composition for treating facial neuritis
CN104825856A (en) * 2015-04-16 2015-08-12 湖州品创孵化器有限公司 Traditional Chinese medicinal composition for treating facial paralysis

Also Published As

Publication number Publication date
CN103169940B (en) 2014-04-09

Similar Documents

Publication Publication Date Title
CN103007216B (en) Chinese medicinal composition for treating chronic diarrhea
CN104147572A (en) Cold and fever wind-dispelling and heat-dispersing preparation and preparation method
CN102688384B (en) Traditional Chinese medicine decoction for treating chronic pharyngitis
CN103169940B (en) Drug for treating facioplegia
CN103041271B (en) Traditional Chinese medicine composition for treating emphysema
CN101204494B (en) Medicine for chronic enteritis
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN103169840B (en) Drug for treating cervical spondylosis
CN103566011B (en) Traditional Chinese medicine composition for treating thromboangiitis obliterans and preparation method thereof
CN103623357A (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis and formula thereof
CN105663874A (en) Traditional Chinese medicine composition for treating chronic rhinitis
CN105963529A (en) Medicinal liquor for curing scabies and preparation method thereof
CN104758554A (en) Traditional Chinese medicine composition for treating headache
CN103169899B (en) Drug for treating hydrops articuli
CN104491331B (en) A kind of pharmaceutical composition with antitussive action
CN105362452A (en) Medicine for treating Raynaud disease
CN104189815A (en) Traditional Chinese medicine preparation for treating children bronchial asthma
CN105287724A (en) Medicine for treating facioplegia
CN104000908A (en) Traditional Chinese medicine for treating pediatric pneumonia and preparation method thereof
CN103385971A (en) Traditional Chinese medicine composition for treating acne
CN104689266A (en) Traditional Chinese medicine for treating chill cold in summer
CN103479953A (en) Method for preparing medicine with function of tonifying spleen to promote digestion
CN105748708A (en) Traditional Chinese medicine for treating chronic urticaria
CN104399041A (en) Medicament for treating allergic rhinitis and preparation method thereof
CN105521142A (en) Aplastic anemia treating drug

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HAIMEN ZHAOYANG INDUSTRY CO., LTD.

Free format text: FORMER OWNER: XUE HONGXI

Effective date: 20150310

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 276800 RIZHAO, SHANDONG PROVINCE TO: 226100 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20150310

Address after: Si Jia Zhen Ren Min Lu Haimen City 226100 Jiangsu city of Nantong province No. 438

Patentee after: HAIMEN MINGYANG INDUSTRIAL CO.,LTD.

Address before: 276800 No. 35, hope road, Shandong, Rizhao City

Patentee before: Xue Hongxi

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140409

CF01 Termination of patent right due to non-payment of annual fee